English 
French 
Spanish 
Chinese 
Japanese 
Korean 
Hindi 
German 
Norwegian 
The immoral profit of pharmaceutical companies selling insulin in the United States
Information
Video published by The New York Times
This video, posted recently on the New York Times channel, denounces the corruption of American leaders, who use money from pharmaceutical companies for their campaigns at the expense of diabetics.
Patent laws allow pharmaceutical companies to block competition and prevent affordable generics.
In recent years, the price of insulin has risen dramatically in the USA (from $44 to $275 per vial) and has become unaffordable. Some diabetics buy it on the black market, while others cross the border into Mexico to build up a large supply and get it for 5 to 10% of the American price.
Lilly, Novo Nordisk and Sanofi are the main corporations immorally making money off the backs of sick people.
Sadly, some insurance plans no longer covering reimbursement for vials of insulin are causing deaths among people who can no longer afford to obtain it.
The immoral profit of pharmaceutical companies selling insulin in the United States
Information
Video published by The New York Times
This video, posted recently on the New York Times channel, denounces the corruption of American leaders, who use money from pharmaceutical companies for their campaigns at the expense of diabetics.
Patent laws allow pharmaceutical companies to block competition and prevent affordable generics.
In recent years, the price of insulin has risen dramatically in the USA (from $44 to $275 per vial) and has become unaffordable. Some diabetics buy it on the black market, while others cross the border into Mexico to build up a large supply and get it for 5 to 10% of the American price.
Lilly, Novo Nordisk and Sanofi are the main corporations immorally making money off the backs of sick people.
Sadly, some insurance plans no longer covering reimbursement for vials of insulin are causing deaths among people who can no longer afford to obtain it.
The immoral profit of pharmaceutical companies selling insulin in the United States
Information
Video published by The New York Times
This video, posted recently on the New York Times channel, denounces the corruption of American leaders, who use money from pharmaceutical companies for their campaigns at the expense of diabetics.
Patent laws allow pharmaceutical companies to block competition and prevent affordable generics.
In recent years, the price of insulin has risen dramatically in the USA (from $44 to $275 per vial) and has become unaffordable. Some diabetics buy it on the black market, while others cross the border into Mexico to build up a large supply and get it for 5 to 10% of the American price.
Lilly, Novo Nordisk and Sanofi are the main corporations immorally making money off the backs of sick people.
Sadly, some insurance plans no longer covering reimbursement for vials of insulin are causing deaths among people who can no longer afford to obtain it.
